Metformin inhibits esophageal squamous cell carcinoma-induced angiogenesis by suppressing JAK/STAT3 signaling pathway.
about
Metformin inhibits esophageal squamous cell carcinoma-induced angiogenesis by suppressing JAK/STAT3 signaling pathway.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Metformin inhibits esophageal ...... g JAK/STAT3 signaling pathway.
@en
Metformin inhibits esophageal ...... g JAK/STAT3 signaling pathway.
@nl
type
label
Metformin inhibits esophageal ...... g JAK/STAT3 signaling pathway.
@en
Metformin inhibits esophageal ...... g JAK/STAT3 signaling pathway.
@nl
prefLabel
Metformin inhibits esophageal ...... g JAK/STAT3 signaling pathway.
@en
Metformin inhibits esophageal ...... g JAK/STAT3 signaling pathway.
@nl
P2093
P2860
P356
P1433
P1476
Metformin inhibits esophageal ...... g JAK/STAT3 signaling pathway.
@en
P2093
Dongyu Wang
Guoguo Jin
Hangfan Liu
Jimin Zhao
Kangdong Liu
Ruihua Bai
Xinhuan Chen
Yanan Jang
P2860
P304
74673-74687
P356
10.18632/ONCOTARGET.20341
P407
P577
2017-08-18T00:00:00Z